Novartis launches first smartphone-enabled study in MS

07:26 EDT 22 Aug 2017 | pharmaphorum

Novartis has launched a research study for people with multiple sclerosis (MS) that collects data via their smartphone. The study is not a ‘classical’ clinical trial, and doesn’t involve the testing of an investigational medicine. Instead...

Original Article: Novartis launches first smartphone-enabled study in MS


More From BioPortfolio on "Novartis launches first smartphone-enabled study in MS"

Quick Search


Relevant Topics

Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...